Online Program

Moving Beyond Pink: To End Breast Cancer Disparities

Monday, November 4, 2013 : 11:30 a.m. - 11:45 a.m.

Valerie L. Rochester, MPA, Black Women’s Health Imperative, Washington, DC
The breast cancer movement is one of the most successful women's health movements in the U.S. It is the most visible and recognized example of women's health activism. Breast cancer advocates, using the pink ribbon as a symbol of the movement, through direct action, have played an important role in research and medical advances that have improved breast cancer early detection, diagnosis and treatment.

Noticeably absent from the breast cancer movement have been the voices of women of color, especially black women. Guided by the principle that all women should benefit from advances made in early detection and treatment therapies, this workshop will call attention to the inequities that contribute to racial differences in breast cancer incidence. We will also add to the science and share best practices and lessons learned through our work with Black women in Chicago and Atlanta.

Learning Areas:

Diversity and culture

Learning Objectives:
Discuss the science of what is known about Black women and breast cancer. Formulate the discussion by sharing best practices and lessons learned from our work addressing breast cancer disparities in Atlanta and Chicago.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a longtime public health professional, with more than 23 years of experience providing programmatic, administrative, management and capacity building training and technical assistance services. As Director of Programs and Training with the Black Women’s Health Imperative, I manage the organization’s national and community-level health initiatives to address the unequal health burdens borne by Black women.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.